Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
Aslan Pharmaceuticals Ltd
Cash from Investing Activities
Aslan Pharmaceuticals Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
|
Cash from Investing Activities
$16.8m
|
CAGR 3-Years
1 089%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Aslan Pharmaceuticals Ltd's Cash from Investing Activities?
Cash from Investing Activities
16.8m
USD
Based on the financial report for Sep 30, 2023, Aslan Pharmaceuticals Ltd's Cash from Investing Activities amounts to 16.8m USD.
What is Aslan Pharmaceuticals Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
1 089%
The average annual Cash from Investing Activities growth rates for Aslan Pharmaceuticals Ltd have been 1 089% over the past three years .